The Cochrane Colorectal Cancer group aim is to prepare and update Cochrane Systematic Reviews within the following topics: Colorectal diseases, Appendiceal diseases, small bowel diseases, surgical aspects of inflammatory bowel diseases, peritoneal diseases, and abdominal hernia diseases.
Cochrane Hepato-Biliary group is made up of people committed to preparing, maintaining, and disseminating systematic reviews about the benefits and harms of interventions used in patients with hepato-biliary diseases.
Cochrane Inflammatory Bowel Disease mission is to perform systematic reviews of health care interventions directed at ulcerative colitis and Crohn's disease with a secondary interest in other intestinal disorders including Clostridium difficile-associated diarrhea, antibiotic-associated diarrhea, microscopic colitis, collagenous colitis, lymphocytic colitis, irritable bowel syndrome, chronic constipation and diarrhea.
Cochrane Kidney and Transplant is concerned with the evaluation of care relevant to patients with kidney disease and with complications of diabetes and hypertension. They also evaluate the means of managing problems associated with interventions for kidney diseases (chronic care, prevention, treatment, rehabilitation and side effects of medication).
Cochrane Metabolic and Endocrine Disorders is primarily concerned with the evaluation of randomised controlled trials and other controlled health care interventions relevant to the prevention, treatment or management, and rehabilitation of metabolic, nutritional and endocrine disorders (such as diabetes mellitus, obesity and thyroid diseases).
Cochrane Upper GI and Pancreatic Diseases aims to use evidence from randomised controlled trials to answer practical questions on the prevention, treatment and rehabilitation of benign and malignant upper gastrointestinal and pancreatic diseases. This includes disorders of the oesophagus, stomach, duodenum and pancreas.